Site Map
- China is filling the global COVID vaccine shortage left by the U.S. and India
- New European regulations require tech companies to prove A.I. is trustworthy
- Black banking execs on what needs to be done to sustain changes in the finance industry after George Floyd’s murder
- On circumventing systemic biases
- An at-home COVID treatment could be available by the end of 2021
- New Census data could lead to a Republican landslide in midterm elections
- IRS is running behind on issuing refunds
- 165,000 women left the U.S. labor force in April, reversing a months-long trend of improving numbers
- Will Elon Musk’s SNL appearance help Dogecoin break $1?
- Bank of England governor: Cryptocurrency investors should be prepared to lose all their money
- To raise COVID vaccination rates, rely on primary care physicians
- What does it really take to be a unicorn founder?
- What percent of unicorns fail?
- The U.S. added just 266,000 jobs in April—sparking hiring concerns despite economic recovery
- Hospitals are charging hundreds per COVID test. Will insurance premiums rise to compensate?
- What if: Elon Musk meets the Coneheads
- This pandemic shortage is far more serious than lumber or toilet paper
- Adidas reports strong growth, raises outlook as it banks on sporting events
- Sustainability must be measured—or claims of greenwashing will be hard to dispel
- You’re heading back to the office. If she has her way, there will be nap time
- Cathie Wood’s Ark fund takes a beating as tech stocks fall
- What Elon Musk can learn from the 3 other business tycoons who have hosted SNL
- The vaccine-patent debate heats up
- Copper soars ahead of what could be a blowout jobs report
- At these companies, A.I. is already driving revenue growth
- From tech to an Honest IPO, here’s what mattered to CFOs this week
- The markets are running a bit too hot, the Fed warns ‘ebullient’ investors
- This fintech company will pay off student loans for employees
- Nintendo won the pandemic. How will the gamemaker confront COVID’s end?
- Shares of Asian vaccine makers rebound from patent waiver shock after Merkel intervenes
- Careers
- Entertainment
- Venture Capital
- Coronavirus
- Autos
- China
- Markets
- The Travel Industry
- Energy
- A.I.
- Bitcoin
- Food and Drink
- Sports
- Luxury
- Politics
- Economy
- Cybersecurity
- Real Estate
- Russia
- Startups
- Diversity and Inclusion
- Elections
- Inflation
- Chief Executive Officer (CEO)
- Investing
- Earnings
- Social Media
- Taxes
- Climate Change
- IPOs
- Netflix
- Pharmaceutical Industry
- Federal Reserve
- Labor
- Mergers and Acquisitions
- Electric Vehicles
- Private Equity
- Congress
- Housing
- Unemployment
- Remote Work
- Banks
- Interest Rates
- Mental Health
- Layoffs
- Human Resources
- Student Loans and Debt
- Gen Z
- Wealth
- Nutrition